Clinical Trial Update: Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating oxymetazoline eye drops for acquired blepharoptosis due to synkinesis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharoptosis
• Facial Paralysis
• Hyperkinesis
• Synkinesis

Drugs mentioned

• Oxymetazoline ophthalmic solution (Oxymetazoline)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Blepharoptosis, Synkinesis | Phase 3 | Status: COMPLETED